Drug Prices
In an evaluation of 49 top-selling brand-name drugs, 28 of the drugs available since 2012 saw an increase in insurer and out-of-pocket costs of more than 50 percent by 2017 and 16 more than doubled in price, according to a study reported Friday in JAMA Network Open.
Ways and Means Committee Chairman Richard Neal, D-Mass., and Energy and Commerce Committee Chairman Frank Pallone Jr., D-N.J., along with Ranking Members Kevin Brady, R-Texas, and Greg Walden, R-Ore., yesterday announced that they are seeking comments on draft legislation to reform and improve the…
To understand what’s really driving Amazon's moves in pharmacy, it’s important to know the back story of Amazon’s $750 million-plus acquisition of PillPack, an online pharmacy for most medications that consumers can get from their local drugstores. PillPack sorts all of a customer’s medications by…
he House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug costs and strengthen the Affordable Care Act’s health insurance marketplaces.
The Centers for Medicare & Medicaid Services May 16 released a final rule with the intent of lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
AHA applauds the U.S. House of Representatives for considering the Strengthening
Health Care and Lowering Prescription Drug Costs Act.
Drug companies are at it again. And their latest effort to divert the focus from the huge profits they pocket as drug prices rise is just as disingenuous as all of their previous attempts.
The House Energy and Commerce Subcommittee on Health today held a hearing on lowering prescription drugs prices, which focused on the drug supply chain.
The House of Representative today passed two AHA-supported bills to promote generic and biosimilar competition in the prescription drug market.
The Centers for Medicare & Medicaid Services (CMS) today released a final rule aimed at increasing drug price transparency and reducing the price of prescription drugs and biological products for consumers.